209 related articles for article (PubMed ID: 19641475)
21. Age as predictor in patients with cutaneous melanoma submitted to sentinel lymph node biopsy.
Caracò C; Marone U; Botti G; Celentano E; Lastoria S; Mozzillo N
Eur J Surg Oncol; 2006 Nov; 32(9):970-3. PubMed ID: 16996239
[TBL] [Abstract][Full Text] [Related]
22. Lymph node metastases from cutaneous squamous cell carcinoma of the head and neck.
Moore BA; Weber RS; Prieto V; El-Naggar A; Holsinger FC; Zhou X; Lee JJ; Lippman S; Clayman GL
Laryngoscope; 2005 Sep; 115(9):1561-7. PubMed ID: 16148695
[TBL] [Abstract][Full Text] [Related]
23. Ultra-late recurrence (15 years or longer) of cutaneous melanoma.
Tsao H; Cosimi AB; Sober AJ
Cancer; 1997 Jun; 79(12):2361-70. PubMed ID: 9191524
[TBL] [Abstract][Full Text] [Related]
24. Sentinel node in management of malignant melanoma.
Al-Hiari AA; Al-Kaylani H
Saudi Med J; 2002 Dec; 23(12):1462-5. PubMed ID: 12518192
[TBL] [Abstract][Full Text] [Related]
25. Contemporary surgical treatment of advanced-stage melanoma.
Essner R; Lee JH; Wanek LA; Itakura H; Morton DL
Arch Surg; 2004 Sep; 139(9):961-6; discussion 966-7. PubMed ID: 15381613
[TBL] [Abstract][Full Text] [Related]
26. A retrospective observational study of primary cutaneous malignant melanoma patients treated with excision only compared with excision biopsy followed by wider local excision.
McKenna DB; Lee RJ; Prescott RJ; Doherty VR
Br J Dermatol; 2004 Mar; 150(3):523-30. PubMed ID: 15030337
[TBL] [Abstract][Full Text] [Related]
27. Reduced expression of p16 and p27 is correlated with tumour progression in cutaneous melanoma.
Sanki A; Li W; Colman M; Karim RZ; Thompson JF; Scolyer RA
Pathology; 2007 Dec; 39(6):551-7. PubMed ID: 18027257
[TBL] [Abstract][Full Text] [Related]
28. Stage I cutaneous malignant melanoma: risk factors of loco-regional recurrence after wide local excision and clinical perspectives.
Bachaud JM; Shubinski R; Boussin G; Chevreau C; David JM; Viraben R; Bonafé JL; Daly NJ
Eur J Surg Oncol; 1992 Oct; 18(5):442-8. PubMed ID: 1426294
[TBL] [Abstract][Full Text] [Related]
29. Clinical presentation, natural history and prognostic factors in advanced malignant melanoma.
Amer MH; Al-Sarraf M; Vaitkevicius VK
Surg Gynecol Obstet; 1979 Nov; 149(5):687-92. PubMed ID: 505243
[TBL] [Abstract][Full Text] [Related]
30. Highly sensitive multivariable assay detection of melanocytic differentiation antigens and angiogenesis biomarkers in sentinel lymph nodes with melanoma micrometastases.
Vitoux D; Mourah S; Kerob D; Verola O; Basset-Seguin N; Baccard M; Schartz N; Ollivaud L; Archimbaud A; Servant JM; Revol M; Toubert ME; Podgorniak MP; Plassa F; Porcher R; Lebbé C
Arch Dermatol; 2009 Oct; 145(10):1105-13. PubMed ID: 19841396
[TBL] [Abstract][Full Text] [Related]
31. Age and gender are significant independent predictors of survival in primary cutaneous melanoma.
Lasithiotakis K; Leiter U; Meier F; Eigentler T; Metzler G; Moehrle M; Breuninger H; Garbe C
Cancer; 2008 Apr; 112(8):1795-804. PubMed ID: 18306371
[TBL] [Abstract][Full Text] [Related]
32. Noncutaneous melanoma have distinct features from each other and cutaneous melanoma.
Tas F; Keskin S; Karadeniz A; Dağoğlu N; Sen F; Kilic L; Yildiz I
Oncology; 2011; 81(5-6):353-8. PubMed ID: 22248874
[TBL] [Abstract][Full Text] [Related]
33. [Melanomas more serious in the elderly].
van der Meijden WA; van Bruchem-Visser RL; Thio HB; van der Cammen TJ
Ned Tijdschr Geneeskd; 2010; 154():A1535. PubMed ID: 20482904
[TBL] [Abstract][Full Text] [Related]
34. Risk factors for the development of locoregional cutaneous metastases as the sole form of recurrence in patients with melanoma.
Messeguer F; Agustí-Mejías A; Traves V; Alegre V; Oliver V; Nagore E
Actas Dermosifiliogr; 2013 Jan; 104(1):53-60. PubMed ID: 23010018
[TBL] [Abstract][Full Text] [Related]
35. Characteristics associated with early and late melanoma metastases.
Brauer JA; Wriston CC; Troxel AB; Elenitsas R; Shin DB; Guerry D; Ming ME
Cancer; 2010 Jan; 116(2):415-23. PubMed ID: 19918926
[TBL] [Abstract][Full Text] [Related]
36. Mitotic rate and subcutaneous involvement are prognostic factors for survival after recurrence in patients with only locoregional skin metastasis as the first site of recurrence from cutaneous melanoma.
Messeguer F; Agustí-Mejías A; Traves V; Requena C; Alegre V; Guillén C; Oliver V; Nagore E
J Eur Acad Dermatol Venereol; 2013 Apr; 27(4):436-41. PubMed ID: 22303982
[TBL] [Abstract][Full Text] [Related]
37. Recurrence of cutaneous malignant melanoma after more than 20 years.
Bredgaard R; Lock-Andersen J
J Plast Surg Hand Surg; 2011 Apr; 45(2):113-6. PubMed ID: 21504283
[TBL] [Abstract][Full Text] [Related]
38. Response, survival, and prognostic factors after hepatic arterial chemoembolization in patients with liver metastases from cutaneous melanoma.
Ahrar J; Gupta S; Ensor J; Ahrar K; Madoff DC; Wallace MJ; Murthy R; Tam A; Hwu P; Bedikian AY
Cancer Invest; 2011 Jan; 29(1):49-55. PubMed ID: 21166498
[TBL] [Abstract][Full Text] [Related]
39. Effects of chronic lymphocytic leukemia on the development and progression of malignant melanoma.
Brewer JD; Christenson LJ; Weenig RH; Weaver AL
Dermatol Surg; 2010 Mar; 36(3):368-76. PubMed ID: 20100262
[TBL] [Abstract][Full Text] [Related]
40. [Late metastasis in malignant melanoma of the skin].
Landthaler M; Braun-Falco O; Schlamminger F; Schubert-Fritschle G
Dtsch Med Wochenschr; 1989 Jul; 114(30):1149-52. PubMed ID: 2752919
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
